2,243
Views
2
CrossRef citations to date
0
Altmetric
Clinical Focus: Pain Management - Editorial

Challenges and opportunities to change the course of the opioid epidemic: a surgeon’s perspective

Pages 1-4 | Received 03 Nov 2016, Accepted 01 Dec 2016, Published online: 22 Dec 2016

References

  • Centers for Disease Control and Prevention. 2016. Understanding the epidemic; [cited 2016 Oct 24]. Available from: https://www.cdc.gov/drugoverdose/epidemic/
  • Veterans Health Administration, Geriatrics and Extended Care Strategic Healthcare Group, National Pain Management Coordinating Committee. Pain as the 5th vital sign toolkit; [ cited 2016 Oct 27]. Available from: http://www.va.gov/painmanagement/docs/toolkit.pdf
  • Lippe PM. The decade of pain control and research. Pain Med. 2000;1(4):286.
  • Centers for Medicare & Medicaid Services. HCAHPS: patients’ perspectives of care survey; [ cited 2016 Oct 27]. Available from: https://www.cms.gov/Medicare/Quality-Initiatives-patient-assessment-instruments/hospitalqualityinits/hospitalhcahps.html
  • Agarin T, Trescot AM, Agarin A, et al. Reducing opioid analgesic deaths in America: what health providers can do. Pain Physician. 2015;18(3):E307–E322.
  • Kessler ER, Shah M, Gruschkus SK, et al. Cost and quality implications of opioid-based postsurgical pain control using administrative claims data from a large health system: opioid-related adverse events and their impact on clinical and economic outcomes. Pharmacotherapy. 2013;33(4):383–391.
  • Alam A, Gomes T, Zheng H, et al. Long-term analgesic use after low-risk surgery: a retrospective cohort study. Arch Intern Med. 2012;172(5):425–430.
  • Sun EC, Darnall BD, Baker LC, et al. Incidence of and risk factors for chronic opioid use among opioid-naive patients in the postoperative period. JAMA Intern Med. 2016;176(9):1286–1293.
  • Carroll I, Barelka P, Wang CK, et al. A pilot cohort study of the determinants of longitudinal opioid use after surgery. Anesth Analg. 2012;115(3):694–702.
  • Cicero TJ, Surratt H, Inciardi JA, et al. Relationship between therapeutic use and abuse of opioid analgesics in rural, suburban, and urban locations in the United States. Pharmacoepidemiol Drug Saf. 2007;16(8):827–840.
  • The Medical Letter, Inc. Abuse-deterrent opioid formulations. Med Lett Drugs Ther. 2015;57(1476):119–121.
  • Viscusi ER, Webster L, Kuss M, et al. A randomized, phase 2 study investigating TRV130, a biased ligand of the mu-opioid receptor, for the intravenous treatment of acute pain. Pain. 2016;157(1):264–272.
  • DeWire SM, Yamashita DS, Rominger DH, et al. A G protein-biased ligand at the mu-opioid receptor is potently analgesic with reduced gastrointestinal and respiratory dysfunction compared with morphine. J Pharmacol Exp Ther. 2013;344(3):708–717.
  • Drug Enforcement Administration, Department of Justice. 21 CFR Part 1308. Schedules of controlled substances: rescheduling of hydrocodone combination products from schedule III to schedule II. Final rule. Fed Regist. 2014;79(163):49659–49661.
  • Weiland BM, Wach AG, Kanar BP, et al. Use of opioid pain relievers following extraction of third molars. Compend Contin Educ Dent. 2015;36(2):107–111.
  • Compton WM, Jones CM, Baldwin GT. Relationship between nonmedical prescription-opioid use and heroin use. N Engl J Med. 2016;374(2):154–163.
  • Cicero TJ, Ellis MS. Nonmedical prescription-opioid use and heroin use. N Engl J Med. 2016;374(13):1295–1296.
  • Compton WM, Jones CM, Baldwin GT. Nonmedical prescription-opioid use and heroin use. N Engl J Med. 2016;374(13):1296.
  • Barrington JW, Halaszynski TM, Sinatra RS, et al. Perioperative pain management in hip and knee replacement surgery. Am J Orthop. 2014;43(Suppl 4):S1–S16.
  • Chou R, Gordon DB, de Leon-Casasola OA, et al. Management of postoperative pain: a clinical practice guideline from the American Pain Society, the American Society of Regional Anesthesia and Pain Medicine, and the American Society of Anesthesiologists’ Committee on Regional Anesthesia, Executive Committee, and Administrative Council. J Pain. 2016;17(2):131–157.
  • Yi P, Pryzbylkowski P. Opioid induced hyperalgesia. Pain Med. 2015;16(Suppl 1):S32–S36.
  • Guignard B, Bossard AE, Coste C, et al. Acute opioid tolerance: intraoperative remifentanil increases postoperative pain and morphine requirement. Anesthesiology. 2000;93(2):409–417.
  • Chia YY, Liu K, Wang JJ, et al. Intraoperative high dose fentanyl induces postoperative fentanyl tolerance. Can J Anaesth. 1999;46(9):872–877.
  • Rawal N. Current issues in postoperative pain management. Eur J Anaesthesiol. 2016;33(3):160–171.
  • Bakan M, Umutoglu T, Topuz U, et al. Opioid-free total intravenous anesthesia with propofol, dexmedetomidine and lidocaine infusions for laparoscopic cholecystectomy: a prospective, random-ized, double-blinded study. Braz J Anesthesiol. 2015;65(3):191–199.
  • Mansour MA, Mahmoud AA, Geddawy M. Nonopioid versus opioid based general anesthesia technique for bariatric surgery: a randomized double-blind study. Saudi J Anaesth. 2013;7(4):387–391.
  • Ziemann-Gimmel P, Goldfarb AA, Koppman J, et al. Opioid-free total intravenous anaesthesia reduces postoperative nausea and vomiting in bariatric surgery beyond triple prophylaxis. Br J Anaesth. 2014;112(5):906–911.
  • Gaszynski T, Gaszynska E, Szewczyk T. Dexmedetomidine for awake intubation and an opioid-free general anesthesia in a superobese patient with suspected difficult intubation. Drug Des Devel Ther. 2014;8:909–912.
  • Bugada D, Guardia Nicola F, Carboni V, et al. TAP block for opioid-free postoperative analgesia in obese surgery. Minerva Anestesiol. 2013;79(12):1447–1448.
  • American Society of Anesthesiologists Task Force on Acute Pain Management. Practice guidelines for acute pain management in the perioperative setting: an updated report by the American Society of Anesthesiologists Task Force on acute pain management. Anesthesiology. 2012;116(2):248–273.
  • Bergese SD, Ramamoorthy S, Patou G, et al. Efficacy profile of liposome bupivacaine, a novel formulation of bupivacaine for postsurgical analgesia. J Pain Res. 2012;5:107–116.
  • Viscusi ER, Sinatra R, Onel E, et al. The safety of liposome bupivacaine, a novel local analgesic formulation. Clin J Pain. 2014;30(2):102–110.
  • Dasta J, Ramamoorthy S, Patou G, et al. Bupivacaine liposome injectable suspension compared with bupivacaine HCl for the reduction of opioid burden in the postsurgical setting. Curr Med Res Opin. 2012;28(10):1609–1615.
  • Cullen KA, Hall MJ, Golosinskiy A. Ambulatory surgery in the United States, 2006. Natl Health Stat Report. 2009;11:1–25.
  • Joshi GP, Schug SA, Kehlet H. Procedure-specific pain management and outcome strategies. Best Pract Res Clin Anaesthesiol. 2014;28(2):191–201.
  • Dowell D, Haegerich TM, Chou R. CDC guideline for prescribing opioids for chronic pain-United States, 2016. JAMA. 2016;315(15):1624–1645.
  • Volkow ND, McLellan TA, Cotto JH, et al. Characteristics of opioid prescriptions in 2009. JAMA. 2011;305(13):1299–1301.
  • Levy B, Paulozzi L, Mack KA, et al. Trends in opioid analgesic-prescribing rates by specialty, U.S., 2007-2012. Am J Prev Med. 2015;49(3):409–413.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.